Australian Veterinary Healthcare Market to 2023 by Product, Animal, and Geography - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 10, 2018--The “Australia Veterinary Healthcare Market - Segmented by Product, Animal, Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The Australia Veterinary Healthcare market is expected to register a CAGR of around 11% during the forecast period, 2018 to 2023.
Increasing Productivity at the Risk of Emerging Zoonosis
The growing meat consumption, especially of chicken and pork, is adding to the exposure of dangerous foodborne pathogens. E. coli and Salmonella infections cause serious diseases among people, and can even be fatal at times, which is possible during the intensive production systems.
Moreover, there is a risk of emerging new strains of influenza viruses, due to the long distance transportation of animals. The farms are often in the same area, with a concentration of confined animals, which potentially enhances the risk of avian influenza transferring to pigs. The reassortment of the virus can lead to new strains and cause infections among humans. Further, these farms increase the risk of spreading and mixing of virus strains. Intensive farm practices are causing the risk of emergence of these bacteria in the food, as stressed animals become more susceptible to infection.
The risk from zoonotic diseases is fuelling the market for Australia veterinary healthcare. Inter-Governmental Organizations and the food production are making reforms to ensure health by the process of surveillance and vaccination, investing in R&D, and transfer with respect to vet health.
Additionally, advanced technology leading to innovations in animal healthcare is also a factor responsible for the growth of Australia veterinary healthcare market.
Key HighlightsUse of Counterfeit Medicines The Vaccine Segment is Expected to Lead the Market
Developments in the MarketJune 2018: Elanco Animal Health introduced New Respiratory PRRS Vaccine, a modified-live respiratory vaccine, which is effective in the reduction of porcine reproductive and respiratory syndrome (PRRS), respiratory form, in piglets two weeks or older.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the MarketBayer Healthcare Boehringer Ingelheim Ceva Animal Health Inc. Elanco (Elli Lilly & Company) Merck Animal Health Virbac Corporation Zoetis Animal Healthcare
For more information about this report visit https://www.researchandmarkets.com/research/3sw9xl/australian?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180810005306/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Animal Healthcare/Veterinary
KEYWORD: AUSTRALIA AUSTRALIA/OCEANIA
INDUSTRY KEYWORD: HEALTH NATURAL RESOURCES AGRICULTURE VETERINARY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/10/2018 11:50 AM/DISC: 08/10/2018 11:50 AM